MedPath

ENDOFOTONICS PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Evaluating Diagnostic Performance of Spectra IMDx System for Detection of Gastric Cancer and Precancerous Lesions

Not Applicable
Conditions
Gastric Cancer
Gastric Precancerous Lesion
Interventions
Device: Spectra IMDx system
First Posted Date
2021-04-08
Last Posted Date
2021-04-15
Lead Sponsor
Endofotonics Pte Ltd
Target Recruit Count
185
Registration Number
NCT04835246
Locations
🇨🇳

Zhongshan Hospital Xiamen University, Xiamen, Fujian, China

© Copyright 2025. All Rights Reserved by MedPath